MXPA05005370A - Cyanoguanidines and cyanoamidines as erbb2 and egfr inhibitors. - Google Patents

Cyanoguanidines and cyanoamidines as erbb2 and egfr inhibitors.

Info

Publication number
MXPA05005370A
MXPA05005370A MXPA05005370A MXPA05005370A MXPA05005370A MX PA05005370 A MXPA05005370 A MX PA05005370A MX PA05005370 A MXPA05005370 A MX PA05005370A MX PA05005370 A MXPA05005370 A MX PA05005370A MX PA05005370 A MXPA05005370 A MX PA05005370A
Authority
MX
Mexico
Prior art keywords
cyanoamidines
cyanoguanidines
erbb2
egfr inhibitors
treatment
Prior art date
Application number
MXPA05005370A
Other languages
Spanish (es)
Inventor
Joseph P Lyssikatos
Original Assignee
Array Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Array Biopharma Inc filed Critical Array Biopharma Inc
Priority claimed from PCT/US2003/035670 external-priority patent/WO2004046101A2/en
Publication of MXPA05005370A publication Critical patent/MXPA05005370A/en

Links

Abstract

Cyanoguanidine quinazoline and cyanoamidine quinazolamine derivatives that are useful in the treatment of hyperproliferative diseases are disclosed. Use of the compounds of the invention to manufacture therapeutic compositions for the treatment of hyperproliferative diseases in mammals is also disclosed.
MXPA05005370A 2002-11-20 2003-11-10 Cyanoguanidines and cyanoamidines as erbb2 and egfr inhibitors. MXPA05005370A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52754402P 2002-11-20 2002-11-20
PCT/US2003/035670 WO2004046101A2 (en) 2002-11-20 2003-11-10 Cyanoguanidines and cyanoamidines as erbb2 and egfr inhibitors

Publications (1)

Publication Number Publication Date
MXPA05005370A true MXPA05005370A (en) 2006-02-17

Family

ID=36642372

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05005370A MXPA05005370A (en) 2002-11-20 2003-11-10 Cyanoguanidines and cyanoamidines as erbb2 and egfr inhibitors.

Country Status (1)

Country Link
MX (1) MXPA05005370A (en)

Similar Documents

Publication Publication Date Title
WO2004046101A3 (en) Cyanoguanidines and cyanoamidines as erbb2 and egfr inhibitors
MXPA05005223A (en) Diaminotriazoles useful as inhibitors of protein kinases.
GEP20084551B (en) 4-phenylamino-quinazolin-6-yl-amides
TW200634012A (en) 3-amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents
EP1485381B8 (en) Azolylaminoazine as inhibitors of protein kinases
AU2003220299A1 (en) Azinylaminoazoles as inhibitors of protein kinases
AU2003218215A1 (en) Azolylaminoazines as inhibitors of protein kinases
AU2003220300A1 (en) Compositions useful as inhibitors of protein kinases
HK1096673A1 (en) Compositions useful as inhibitors of protein kinases
TNSN05045A1 (en) Indole or benzimidazole derivatives for modulating ikappab kinase
MXPA05005107A (en) Compositions and methods for the diagnosis and treatment of tumor.
UA84167C2 (en) Quinazoline derivatives as tyrosine kinase inhibitors, process for the preparation thereof (variants), pharmaceutical composition based thereon
TW200724543A (en) Heterocyclic compounds and their uses as therapeutic agents
TW200716546A (en) Oxindole compounds and their uses as therapeutic agents
DE60118003D1 (en) UREA DERIVATIVES AND ITS USE
TW200630090A (en) Triazoles useful as inhibitors of protein kinases
IS2855B (en) 4-anilinoquinazoline derivatives as a propagating agent
CY1108146T1 (en) Beta-Amino-Heterocyclic-Dipeptidyl Peptide Suspensions for the Treatment or Prevention of Diabetes
IL181700A0 (en) Quinazoline derivatives and pharmaceutical compositions containing the same
TW200514776A (en) Aminotriazole compounds useful as inhibitors of protein kinases
EP1673078A4 (en) Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
MX2007011545A (en) Combinations for the treatment of cancer comprising anti-egfr antibody and vegfr inhibitors.
SI1789398T1 (en) 2-amino-quinazoline derivatives useful as inhibitors of b-secretase (bace)
EP1858520A4 (en) Quinazolinone t-type calcium channel antagonists
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes